Sanofi and Orano join forces to develop next-generation radioligand medicines Paris, October 17, 2024. Sanofi and Orano Med, a subsidiary of the Orano Group and a pioneer in the development of ...

MSD (Merck & Co) is planning to get its respiratory syncytial virus (RSV) vaccine, clesrovimab, approved and launched before ...

Madison County Board approves multiple vaccine contracts and emergency appropriations, including grants for public health and ...

The FDA has approved updated labeling for Flublok (influenza vaccine) to include new safety data involving pregnant individuals.

Sanofi and Orano Med have partnered to accelerate the development of next-generation radioligand therapies (RLTs) for rare ...